Orange Book product · Generic (ANDA)
DESMOPRESSIN ACETATE
DESMOPRESSIN ACETATE
At a glance
Feb 27, 2026
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 27, 2026
4 mo ago
Today
Pharmaceutical detail
Active ingredient
DESMOPRESSIN ACETATE
Strength
0.004MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 219981
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DESMOPRESSIN ACETATE
- 2026DESMODABrand (NDA)
NDA 219873 · ETON
- 2018NOCDURNABrand (NDA)
NDA 022517 · FERRING PHARMS INC
- 2017NOCTIVABrand (NDA)
NDA 201656 · ACERUS PHARMS
- 2008DESMOPRESSIN ACETATEBrand (NDA)
NDA 021795 · FERRING
- 2002MINIRINBrand (NDA)
NDA 021333 · FERRING
- 1995DDAVPBrand (NDA)
NDA 019955 · FERRING PHARMS INC
- 1994STIMATEBrand (NDA)
NDA 020355 · FERRING PHARMS INC
- 1990CONCENTRAIDBrand (NDA)
NDA 019776 · FERRING
- 1984DDAVPBrand (NDA)
NDA 018938 · NORDIC PHARMA
- —DDAVPBrand (NDA)
NDA 017922 · FERRING PHARMS INC
- 2024DESMOPRESSIN ACETATEGeneric (ANDA)
ANDA 213095 · AUROBINDO PHARMA
- 2023DESMOPRESSIN ACETATEGeneric (ANDA)
ANDA 216904 · GLAND
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
